{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:54:40Z","timestamp":1782744880841,"version":"3.54.5"},"reference-count":115,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Atherosclerotic cardiovascular disease confers significant morbidity and mortality in patients with systemic lupus erythematosus (SLE) and cannot be fully explained by traditional cardiovascular risk factors. Recent immunologic discoveries have outlined putative pathways in SLE that may also accelerate the development of atherosclerosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Aberrant innate and adaptive immune responses implicated in lupus pathogenesis may also contribute to the development of accelerated atherosclerosis in these patients. Defective apoptosis, abnormal lipoprotein function, autoantibodies, aberrant neutrophil responses, and a dysregulated type I interferon pathway likely contribute to endothelial dysfunction. SLE macrophages have an inflammatory phenotype that may drive progression of plaque.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Recent discoveries have placed increased emphasis on the immunology of atherosclerotic cardiovascular disease. Understanding the factors that drive the increased risk for cardiovascular disease in SLE patients may provide selective therapeutic targets for reducing inflammation and improving outcomes in atherosclerosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000307","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T11:21:04Z","timestamp":1464175264000},"page":"468-476","source":"Crossref","is-referenced-by-count":56,"title":["Update on cardiovascular disease in lupus"],"prefix":"10.1097","volume":"28","author":[{"given":"Laura B.","family":"Lewandowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230828","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.3899\/jrheum.080214","article-title":"Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus","volume":"35","author":"Urowitz","year":"2008","journal-title":"J Rheumatol"},{"key":"R2-20230828","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1177\/0961203314551083","article-title":"Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study","volume":"23","author":"Lerang","year":"2014","journal-title":"Lupus"},{"key":"R3-20230828","first-page":"713","article-title":"Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964\u201395","volume":"31","author":"Bj\u00f6rn\u00e5dal","year":"2004","journal-title":"J Rheumatol"},{"key":"R4-20230828","first-page":"1","article-title":"Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study","volume":"0","author":"Lai","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R5-20230828","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/ard.62.11.1071","article-title":"Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus","volume":"62","author":"Doria","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"(suppl 1)","key":"R6-20230828","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.06.010","article-title":"Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus","volume":"121","author":"Salmon","year":"2008","journal-title":"Am J Med"},{"key":"R7-20230828","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R8-20230828","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.849166","article-title":"Cardiovascular risk prediction: basic concepts, current status, and future directions","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"R9-20230828","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1517\/14740338.2015.1073259","article-title":"Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review","volume":"14","author":"Gatto","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"R10-20230828","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/acr.20122","article-title":"Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus","volume":"62","author":"Urowitz","year":"2010","journal-title":"Arthritis Care Res"},{"key":"R11-20230828","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","article-title":"Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R12-20230828","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-20230828","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/art.39423","article-title":"Impact of disease duration on vascular surrogates of early atherosclerosis in childhood-onset systemic lupus erythematosus","volume":"68","author":"Barsalou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R14-20230828","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","article-title":"Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis","volume":"15","author":"Wu","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R15-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.201500131","article-title":"Specific autoantigens in experimental autoimmunity-associated atherosclerosis","volume":"30","author":"Merched","year":"2016","journal-title":"FASEB J"},{"key":"R16-20230828","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.4049\/jimmunol.1402807","article-title":"IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis","volume":"194","author":"Watkins","year":"2015","journal-title":"J Immunol"},{"key":"R17-20230828","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2003-09-3198","article-title":"Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity","volume":"103","author":"Rajagopalan","year":"2004","journal-title":"Blood"},{"key":"R18-20230828","first-page":"2372","article-title":"Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities","volume":"27","author":"Bruce","year":"2000","journal-title":"J Rheumatol"},{"key":"R19-20230828","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/0961203315622822","article-title":"Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis","volume":"25","author":"Sharma","year":"2016","journal-title":"Lupus"},{"key":"R20-20230828","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehw018","article-title":"Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases","author":"Faccini","year":"2016","journal-title":"Eur Heart J"},{"key":"R21-20230828","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.201412052","article-title":"Recent insights into the cellular biology of atherosclerosis","volume":"209","author":"Tabas","year":"2015","journal-title":"J Cell Biol"},{"key":"R22-20230828","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/eurheartj\/ehs411","article-title":"Update on acute coronary syndromes: the pathologists\u2019 view","volume":"34","author":"Falk","year":"2013","journal-title":"Eur Heart J"},{"key":"R23-20230828","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/eji.201141719","article-title":"The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis","volume":"41","author":"Thorp","year":"2011","journal-title":"Eur J Immunol"},{"key":"R24-20230828","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/08916934.2012.719953","article-title":"Apoptosis and NET formation in the pathogenesis of SLE","volume":"45","author":"Bouts","year":"2012","journal-title":"Autoimmunity"},{"key":"R25-20230828","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/joim.12403","article-title":"The changing face of atherosclerotic plaque inflammation","volume":"278","author":"Nilsson","year":"2015","journal-title":"J Intern Med"},{"key":"R26-20230828","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/01.CIR.91.9.2488","article-title":"Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics","volume":"91","author":"Berliner","year":"1995","journal-title":"Circulation"},{"key":"R27-20230828","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/art.23353","article-title":"Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort","volume":"59","author":"Urowitz","year":"2008","journal-title":"Arthritis Care Res"},{"key":"R28-20230828","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1177\/0961203310373937","article-title":"Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort","volume":"19","author":"Ardoin","year":"2010","journal-title":"Lupus"},{"key":"R29-20230828","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.semarthrit.2015.10.010","article-title":"Dyslipidemia in systemic lupus erythematosus: just another comorbidity?","volume":"45","author":"Tselios","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"R30-20230828","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/096120339700600610","article-title":"Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies","volume":"6","author":"Borba","year":"1997","journal-title":"Lupus"},{"key":"R31-20230828","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0140-6736(93)91213-6","article-title":"Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus","volume":"341","author":"Vaarala","year":"1993","journal-title":"Lancet"},{"key":"R32-20230828","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/annrheumdis-2012-202914","article-title":"Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus","volume":"73","author":"Ronda","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R33-20230828","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/art.38703","article-title":"Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus","volume":"66","author":"Smith","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"(suppl 1)","key":"R34-20230828","doi-asserted-by":"crossref","first-page":"i180","DOI":"10.1093\/rheumatology\/keu128.003","article-title":"Serum anti-apolipoprotein 1 antibodies are present in a quarter of patients with systemic lupus erythematosus at the time of diagnosis and are associated with earlier mortality","volume":"53","author":"Croca","year":"2014","journal-title":"Rheumatology"},{"key":"R35-20230828","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/acr.22430","article-title":"Apolipoprotein-containing lipoprotein subclasses and subclinical atherosclerosis in systemic lupus erythematosus","volume":"67","author":"Kiani","year":"2015","journal-title":"Arthritis Care Res"},{"key":"R36-20230828","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.11472","article-title":"High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus","volume":"50","author":"Posadas-Romero","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R37-20230828","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/annrheumdis-2012-202106","article-title":"Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort","volume":"72","author":"Parker","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R38-20230828","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/ard.2006.054973","article-title":"High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors","volume":"66","author":"Chung","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R39-20230828","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1191\/096120301669081314","article-title":"Anti-insulin antibodies and the natural autoimmune response in systemic lupus erythematosus","volume":"10","author":"Lidar","year":"2001","journal-title":"Lupus"},{"key":"R40-20230828","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0961203314551811","article-title":"Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus","volume":"24","author":"Sabio","year":"2015","journal-title":"Lupus"},{"key":"R41-20230828","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00296-008-0781-7","article-title":"Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus","volume":"29","author":"Tso","year":"2009","journal-title":"Rheumatol Int"},{"key":"R42-20230828","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0961203315603138","article-title":"Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus","volume":"25","author":"Castejon","year":"2016","journal-title":"Lupus"},{"key":"R43-20230828","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood"},{"key":"R44-20230828","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.34504","article-title":"Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis","volume":"64","author":"Thacker","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R45-20230828","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/art.39149","article-title":"Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus","volume":"67","author":"Mohan","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R46-20230828","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.4049\/jimmunol.1101284","article-title":"Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus","volume":"187","author":"Kahlenberg","year":"2011","journal-title":"J Immunol"},{"key":"R47-20230828","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cmet.2010.06.008","article-title":"Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions","volume":"12","author":"Goossens","year":"2010","journal-title":"Cell Metab"},{"key":"R48-20230828","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/art.30165","article-title":"Interferon-\u03b1 priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-\u03b1 and atherosclerosis in lupus","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R49-20230828","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood-2010-03-274605","article-title":"Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease","volume":"116","author":"Lood","year":"2010","journal-title":"Blood"},{"key":"R50-20230828","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/ATVBAHA.115.306767","article-title":"Effects of long-term type I interferon on the arterial wall and smooth muscle progenitor cells differentiation","volume":"36","author":"Diao","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R51-20230828","doi-asserted-by":"crossref","first-page":"21391","DOI":"10.1038\/srep21391","article-title":"Critical role of the C5a-activated neutrophils in high-fat diet-induced vascular inflammation","volume":"6","author":"Osaka","year":"2016","journal-title":"Sci Rep"},{"key":"R52-20230828","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00281-013-0375-7","article-title":"Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity","volume":"35","author":"Carmona-Rivera","year":"2013","journal-title":"Semin Immunopathol"},{"key":"R53-20230828","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.4049\/jimmunol.0902199","article-title":"A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs","volume":"184","author":"Denny","year":"2010","journal-title":"J Immunol"},{"key":"R54-20230828","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1160\/TH11-09-0650","article-title":"Presence of luminal neutrophil extracellular traps in atherosclerosis","volume":"107","author":"Megens","year":"2012","journal-title":"Thromb Haemost"},{"key":"R55-20230828","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/annrheumdis-2013-204837","article-title":"Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2","volume":"74","author":"Carmona-Rivera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R56-20230828","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"key":"R57-20230828","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.aaa8064","article-title":"Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science"},{"key":"R58-20230828","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.freeradbiomed.2016.01.004","article-title":"Oxidized LDL induced extracellular trap formation in human neutrophils via TLR-PKC-IRAK-MAPK and NADPH-oxidase activation","volume":"93","author":"Awasthi","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"R59-20230828","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/CIRCRESAHA.116.304944","article-title":"Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size","volume":"116","author":"Mangold","year":"2015","journal-title":"Circ Res"},{"key":"R60-20230828","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/eurheartj\/ehv007","article-title":"Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction","volume":"36","author":"Stakos","year":"2015","journal-title":"Eur Heart J"},{"key":"R61-20230828","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/annrheumdis-2013-203430","article-title":"Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease","volume":"73","author":"Kambas","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R62-20230828","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrcardio.2014.173","article-title":"Macrophage subsets in atherosclerosis","volume":"12","author":"Chinetti-Gbaguidi","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"R63-20230828","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/annrheumdis-2013-204351","article-title":"Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment","volume":"74","author":"Ruiz-Limon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R64-20230828","first-page":"151","article-title":"Macrophage subpopulations in systemic lupus erythematosus","volume":"13","author":"Orme","year":"2012","journal-title":"Discov Med"},{"key":"R65-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-005-0353-8","article-title":"Fc receptors and their role in immune regulation and autoimmunity","volume":"25","author":"Takai","year":"2005","journal-title":"J Clin Immunol"},{"key":"R66-20230828","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2010.10.018","article-title":"The inhibitory Fc\u03b3RIIb modulates the inflammatory response and influences atherosclerosis in male apoE\u2212\/\u2212 mice","volume":"214","author":"Mendez-Fernandez","year":"2011","journal-title":"Atherosclerosis"},{"key":"R67-20230828","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/ATVBAHA.114.303569","article-title":"Targeting B cells in atherosclerosis closing the gap from bench to bedside","volume":"35","author":"Tsiantoulas","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R68-20230828","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/cei.12651","article-title":"Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus","volume":"181","author":"Svenungsson","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"R69-20230828","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity"},{"key":"R70-20230828","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.4049\/jimmunol.1000033","article-title":"Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis","volume":"185","author":"Kyaw","year":"2010","journal-title":"J Immunol"},{"key":"R71-20230828","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/annrheumdis-2013-204600","article-title":"Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus","volume":"74","author":"Perez-Sanchez","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R72-20230828","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1177\/2047487314546826","article-title":"Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis","volume":"22","author":"Ballocca","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"R73-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3759","article-title":"Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study","volume":"14","author":"Gustafsson","year":"2012","journal-title":"Arthritis Res Therapy"},{"key":"R74-20230828","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"(suppl 1)","key":"R75-20230828","doi-asserted-by":"crossref","first-page":"i65","DOI":"10.1136\/ard.2009.117135","article-title":"Treg and lupus","volume":"69","author":"Bonelli","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"(suppl 12)","key":"R76-20230828","first-page":"002","article-title":"Regulatory T cells and atherosclerosis","volume":"2012","author":"Pastrana","year":"2012","journal-title":"J Clin Exp Cardiol"},{"key":"R77-20230828","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat Med"},{"key":"R78-20230828","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3899\/jrheum.150460","article-title":"Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: a systematic review","volume":"43","author":"Tselios","year":"2016","journal-title":"J Rheumatol"},{"key":"R79-20230828","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.pcad.2014.10.004","article-title":"Treating coronary disease and the impact of endothelial dysfunction","volume":"57","author":"Matsuzawa","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"key":"R80-20230828","doi-asserted-by":"crossref","first-page":"e44668","DOI":"10.1371\/journal.pone.0044668","article-title":"Early vascular alterations in SLE and RA patients \u2013 a step towards understanding the associated cardiovascular risk","volume":"7","author":"Santos","year":"2012","journal-title":"PloS One"},{"key":"R81-20230828","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/art.38204","article-title":"A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus","volume":"66","author":"McMahon","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R82-20230828","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1161\/ATVBAHA.115.302072","article-title":"S100A12 and the S100\/calgranulins: emerging biomarkers for atherosclerosis and possibly therapeutic targets","volume":"35","author":"Oesterle","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R83-20230828","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1161\/ATVBAHA.114.304306","article-title":"EN-RAGE: a novel inflammatory marker for incident coronary heart disease","volume":"34","author":"Ligthart","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R84-20230828","first-page":"150","article-title":"Salt in the wound: (18)F-fluoride positron emission tomography for identification of vulnerable coronary plaques","volume":"5","author":"Adamson","year":"2015","journal-title":"Cardiovasc Diagn Ther"},{"key":"R85-20230828","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0003319714522849","article-title":"Carotid intimal thickness and plaque predict prevalence and severity of coronary atherosclerosis: a pilot study","volume":"66","author":"Jeevarethinam","year":"2015","journal-title":"Angiology"},{"key":"R86-20230828","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/ajh\/hpv127","article-title":"Repeatability of central and peripheral pulse wave velocity measures: the atherosclerosis risk in communities (ARIC) study","volume":"29","author":"Meyer","year":"2016","journal-title":"Am J Hypertens"},{"key":"R87-20230828","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1253\/circj.CJ-15-1356","article-title":"Prognostic implications of non-invasive vascular function tests in high-risk atherosclerosis patients","volume":"80","author":"Kusunose","year":"2016","journal-title":"Circ J"},{"key":"R88-20230828","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.amjcard.2006.09.125","article-title":"The inflammation hypothesis and its potential relevance to statin therapy","volume":"99","author":"Forrester","year":"2007","journal-title":"Am J Cardiol"},{"key":"R89-20230828","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.4049\/jimmunol.177.10.7416","article-title":"Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus","volume":"177","author":"Jury","year":"2006","journal-title":"J Immunol"},{"key":"R90-20230828","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00210-015-1192-4","article-title":"Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin","volume":"389","author":"Meschiari","year":"2016","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R91-20230828","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijcard.2012.09.190","article-title":"Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus \u2013 a meta-analysis of randomized controlled trials","volume":"167","author":"Ye","year":"2013","journal-title":"Int J Cardiol"},{"key":"R92-20230828","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/annrheumdis-2012-202315","article-title":"Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein","volume":"73","author":"Ardoin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R93-20230828","doi-asserted-by":"crossref","first-page":"e0148210","DOI":"10.1371\/journal.pone.0148210","article-title":"Simvastatin efficiently lowers small LDL-IgG immune complex levels: a therapeutic quality beyond the lipid-lowering effect","volume":"11","author":"Horl","year":"2016","journal-title":"PloS One"},{"key":"R94-20230828","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2015.08.030","article-title":"Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: a nationwide population-based cohort study","volume":"243","author":"Yu","year":"2015","journal-title":"Atherosclerosis"},{"key":"R95-20230828","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3899\/jrheum.150437","article-title":"Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy","volume":"43","author":"Durcan","year":"2016","journal-title":"J Rheumatol"},{"key":"R96-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3895","article-title":"Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"14","author":"Sacre","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R97-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0790-3","article-title":"Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus","volume":"17","author":"Virdis","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R98-20230828","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/art.38703","article-title":"Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus","volume":"66","author":"Smith","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R99-20230828","first-page":"50","article-title":"Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus","volume":"33","author":"El Magadmi","year":"2006","journal-title":"J Rheumatol"},{"key":"R100-20230828","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1002\/art.39296","article-title":"Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin","volume":"67","author":"Wang","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R101-20230828","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/ATVBAHA.115.305378","article-title":"Endothelial PPAR-\u03b3 protects against vascular thrombosis by downregulating P-selectin expression","volume":"35","author":"Jin","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R102-20230828","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1191\/0961203305lu2057oa","article-title":"Prognostic factors in lupus nephritis","volume":"14","author":"Mok","year":"2005","journal-title":"Lupus"},{"key":"R103-20230828","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4049\/jimmunol.0804341","article-title":"The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus","volume":"183","author":"Zhao","year":"2009","journal-title":"J Immunol"},{"key":"R104-20230828","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4049\/jimmunol.182.1.340","article-title":"The peroxisome proliferator-activated receptor \u03b3 agonist rosiglitazone ameliorates murine lupus by induction of adiponectin","volume":"182","author":"Aprahamian","year":"2009","journal-title":"J Immunol"},{"key":"R105-20230828","doi-asserted-by":"crossref","first-page":"e000441","DOI":"10.1161\/JAHA.113.000441","article-title":"The peroxisome proliferator activated receptor-\u03b3 pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis","volume":"2","author":"Marder","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"R106-20230828","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2008.10.033","article-title":"25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey","volume":"205","author":"Kendrick","year":"2009","journal-title":"Atherosclerosis"},{"key":"R107-20230828","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/acr.22291","article-title":"25-Hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort","volume":"66","author":"Lertratanakul","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R108-20230828","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1681\/ASN.2008111157","article-title":"25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification","volume":"20","author":"de Boer","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R109-20230828","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/rheumatology\/ker352","article-title":"25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus","volume":"51","author":"Reynolds","year":"2012","journal-title":"Rheumatology"},{"key":"R110-20230828","doi-asserted-by":"crossref","first-page":"22341","DOI":"10.1038\/srep22341","article-title":"Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus","volume":"6","author":"Reynolds","year":"2016","journal-title":"Sci Rep"},{"key":"R111-20230828","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1159\/000330075","article-title":"1\u03b1,25-Dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells","volume":"27","author":"Molinari","year":"2011","journal-title":"Cell Physiol Biochem"},{"key":"R112-20230828","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MAJ.0000000000000556","article-title":"A pilot study to determine if vitamin D repletion improves endothelial function in lupus patients","volume":"350","author":"Kamen","year":"2015","journal-title":"Am J Med Sci"},{"key":"R113-20230828","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/prca.201500036","article-title":"Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: interleukin-6 receptor-alpha inhibition with tocilizumab","volume":"10","author":"Lee","year":"2016","journal-title":"Proteomics Clin Appl"},{"issue":"(suppl 2)","key":"R114-20230828","article-title":"SAT0099 effect of TNF inhibitors on subclinical atherosclerosis in patients with rheumatoid arthritis: a meta-analysis","volume":"74","author":"Cheung","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R115-20230828","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-208562","article-title":"Sifalimumab, an anti-interferon-\u03b1 monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study","author":"Khamashta","year":"2016","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201609000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T05:31:19Z","timestamp":1693200679000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201609000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000307","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}